Tag: biopharma

Potapov’s appointment follows Takeda’s recent acquisition of Shire Pharmaceuticals – enabling Takeda to become a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan...............

As per the study by IQVIA Institute for Human Data Science, while the likelihood that a drug entering clinical development would be a success was 11 percent, down from 14 percent in 2017, eight identified trends could increase R&D productivity by double digits during next five years.................

The Centre has been set up at Syngene’s campus in Bengaluru by the Biotechnology Industry Research Assistance Council (BIRAC) and will host a state-of-the-art GLP accredited analytical laboratory. The collaboration a part of National Biopharma Mission.............

Lupin Bioresearch Centre (LBC) conducts the in-vivo and in-vitro bioequivalence studies for Lupin in Pune...................

With improved assisted reproductive technology (ART) through higher precision, Merck offers a combined portfolio of drugs and technologies........................

On the first day, the Genome Valley Excellence Award 2019 was presented to Dr Don W. Cleveland of the University of California recognizing his pioneering work in cancer genetics. Also, the Governor of Telangana launched State government’s Vaccine Skilling program...………….

As per the union government, unbranded generic medicines worth Rs 417 crores (MRP) have been sold through 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras that are functional in 35 States/UTs of the country...………..

The top commerce ministry officials of India and China discussed the various issues related to commercial transactions between two nations including widening trade deficit...……….

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

The proposed facility, to come up with an estimated cost of Rs 60 crore, will be set up through Public Private Partnership in Genome Valley, which is India's first organised cluster for life sciences R&D and clean manufacturing activities.